FOXM1 overexpression has also been reported in several tumors, such as hepatocellular, pancreatic, colorectal and laryngeal cancer [11–14], with involvement in different mechanisms of oncogenesis, like cell proliferation, invasion, angiogenesis, and metastasis [15–19]. This evidence concerns the gene FOXM1 and laryngeal carcinoma.